February 21, 2023

Rudy Tanzi and the Latest Alzheimer’s Drugs - part 1

Rudy Tanzi and the Latest Alzheimer’s Drugs - part 1

About This Episode

Will 2023 be a boom or bust year for new Alzheimer’s drugs? 

In this episode of BrainStorm host Meryl Comer talks with Dr. Rudy Tanzi, Vice-Chair of Neurology at Massachusetts General Hospital, Co-Director of the McCance Center for Brain Health and Professor at Harvard Medical School.  Dr. Tanzi discusses the promising new drugs in a highly charged scientific environment and how these drugs have opened the door to advancement in the treatment of Alzheimer’s. 

Support the show

BrainStorm Feed

36

Rebecca Chopp, Ph.D., and Her Unexpected Alzheimer’s Diagnosis (part 1)

Rebecca Chopp, Ph.D., built a life around a profession that prized the mind and then was unexpectedly diagnosed with Alzheimer's disease.

LISTEN NOW
35

Dr. Rudy Tanzi -The Latest on Alzheimer's Drugs (part 2)

BrainStorm host Meryl Comer talks with Dr. Rudy Tanzi, Vice-Chair of Neurology at Massachusetts General Hospital, Co-Director of the McCance Center for Brain Health and Professor at Harvard Medical School.
LISTEN NOW
33

George Vradenburg – The Future of Alzheimer’s Advocacy Part 2

The Food and Drug Administration expedited approval of Lecanemab, a drug developed by Eisai and Biogen, that demonstrated positive results in slowi

LISTEN NOW